Jan01

A year in review: 2018

Tuesday, 01 January 2019 Written by // IMPT Secretariat Staff Tags // action, development, network, New Year

Happy New Year from the IMPT Secretariat!

Recharged from the holiday season, we are proud to share a few major highlights from our 2018 work as IMPT learning network manager – fostering connections between multidisciplinary partners; collecting, synthesizing, and disseminating MPT-relevant information; and accelerating action to advance progress in the field.

Dec01

IMPT Advisory Council: Pioneers for an HIV-free world and more

Saturday, 01 December 2018 Written by // IMPT Secretariat Staff Tags // advisory council, HIV, prevention, product choices, women, World AIDS Day

Every four minutes, three young women will become infected with HIV—that’s close to 900,000 new infections a year. While HIV prevention research and drug development have progressed rapidly, there is still work to be done. This World AIDS Day, we reflect on our work to advance MPTs by asking the IMPT Advisory Council for their perspective on the role of MPTs in the fight to end the HIV epidemic.

Nov20

Market-based targets for MPT development: Expanding the target product profile

Tuesday, 20 November 2018 Written by // IMPT Secretariat Staff Tags // product development, target market

Earlier this year, we wrote a post about Target Product Profiles (TPPs) and the generalized versions that the IMPT developed in 2015 for two MPT product types. As we argue in that post, a product that meets all clinical targets listed in a TPP will not necessarily correlate to its public health impact in the real world. That is, not unless we work to understand what the future end-users of MPTs – who include both the women who will use MPTs to protect their sexual and reproductive health as well as the health providers who will prescribe MPTs for these women – want and need in a product and then integrate those learnings into the product development process. Of course, it is critical that an MPT be efficacious and safe, but how can we expand the product evaluation process to better ensure that future end-users will be able to access, want to try, and continue to use an MPT?

<<  1 2 3 4 5 [67 8 9 10  >>  

Recent Posts

Any thoughts? Contact us to learn more about the submission process.
The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
© Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.